Amarin Corp Plc (AMRN)

[circuitcity]

Disagree here. Yes, generics will benefit one way or another from this if V is proven beneficial to co19 patients; but it also increase EU valuation which is almost the only piece we have.

Beside this is a great opportunity if amrn want to utilize media to influence the appeal court. So I only hope things are happening behind scene as Zu suggested and we wil know soon.